Back to the main directory
EarningsReview / Equity
- FLSmidth (Buy, TP: DKK400.00) - Another transformation year by DnB Markets
- Entra (Hold, TP: NOK105.00) - Continued asset value decline by DnB Markets
- Norion Bank (Buy, TP: SEK53.00) - Market still overstating risk by DnB Markets
- Embla Medical (Buy, TP: DKK39.00) - Solid start to 2024 by DnB Markets
- Vår Energi (Buy, TP: NOK40.00) - Jotun FPSO sail-away in focus by DnB Markets
- DNB (No_rec, TP: NOK) - Trimmed NII, but strong asset quality by DnB Markets
- Cambi Minor model adjustments by DnB Markets
- Almarai (ALMARAI AB) by HSBC
- Q1 beat on margins; ’24 guidance maintained as Q2 outlook disappoints by BNP Paribas
- Tough fightback, tougher odds yet by BNP Paribas
- Itaú BBA on Alsea: Mexico, the Crown Jewel by Itau
- Earnings call feedback by BNP Paribas
- Embla Medical - A good start to the year by Danske Bank Equity Research
- Corem - Hold: Disappointing deviations by Nordea
- Volume lighter (as expected), but initial guide above Street by BNP Paribas
- Beijer Ref - Buy/SEK 203 (199): Forever Young by Nordea
- Embla Medical - Buy/DKK 36 (35.20): Solid run-rate outshines hiccups by Nordea
- Refreshing estimates by BNP Paribas
- Finnair - Buy/EUR 4.10 (4.50): Good demand for the summer season by Nordea
- Nordnet - Buy/SEK 217 (206): All set for further improved trading and net flows by Nordea
- Inwido - Buy/SEK 190 (185): Ready for a rebound by Nordea
- Vaar Energi - Buy/NOK 47: Strong Q1 should leave headroom to FY guidance by Nordea
- Hot Stocks Q2 2024 by BNP Paribas
- The HDD Cycle Is Turning, But What Multiple Should You Pay? by BNP Paribas
- Margins still under some pressure by BNP Paribas